Bio Blast Pharma Shares Outstanding 2013-2019 | ENLV

Bio Blast Pharma shares outstanding from 2013 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Bio Blast Pharma Annual Shares Outstanding
(Millions of Shares)
2018 4
2017 3
2016 0
2015 0
2014 0
2013 0
2012 0
Bio Blast Pharma Quarterly Shares Outstanding
(Millions of Shares)
Q2 2019 10
Q1 2019 4
Q4 2018 4
Q3 2018 72
Q2 2018 4
Q1 2018 4
Q4 2017 3
Q3 2017 70
Q2 2017 0
Q1 2017 0
Q4 2016 0
Q3 2016 0
Q2 2016 0
Q1 2016 0
Q4 2015 0
Q3 2015 0
Q2 2015 0
Q1 2015 0
Q4 2014 0
Q3 2014 0
Q2 2014 0
Q1 2014 0
Q4 2013
Q3 2013 0
Q2 2013 0
Q4 2012
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.336B $0.000B
Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $57.135B 35.19
Astellas Pharma (ALPMY) Japan $28.433B 13.55
Takeda Pharmaceutical (TAK) Japan $27.076B 8.45
Eisai (ESALY) Japan $14.552B 25.02
UCB SA (UCBJF) Belgium $14.267B 0.00
Merck (MKGAF) Germany $14.152B 19.31
Grifols, S.A (GRFS) Spain $13.827B 17.64
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Ionis Pharmaceuticals (IONS) United States $9.151B 19.74
Neurocrine Biosciences (NBIX) United States $8.956B 0.00
Sage Therapeutics (SAGE) United States $8.541B 0.00
IPSEN SA ADR (IPSEY) France $8.529B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.588B 9.99
Catalent (CTLT) United States $7.386B 29.24
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.064B 18.20
Nektar Therapeutics (NKTR) United States $3.719B 0.00
United Therapeutics (UTHR) United States $3.663B 0.00
FibroGen (FGEN) United States $3.635B 90.91
Evotec AG (EVTCY) Germany $3.420B 46.83
Taro Pharmaceutical Industries (TARO) Israel $3.238B 11.61
Tilray (TLRY) Canada $3.006B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.791B 64.00
PTC Therapeutics (PTCT) United States $2.533B 0.00
Portola Pharmaceuticals (PTLA) United States $2.128B 0.00
Xencor (XNCR) United States $2.058B 44.86
Zogenix (ZGNX) United States $1.852B 0.00
Heron Therapeutics (HRTX) United States $1.675B 0.00
USANA Health Sciences (USNA) United States $1.604B 16.08
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.567B 57.01
Corcept Therapeutics (CORT) United States $1.511B 20.77
Ironwood Pharmaceuticals (IRWD) United States $1.510B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.376B 22.69
Radius Health (RDUS) United States $1.339B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.302B 0.00
Aerie Pharmaceuticals (AERI) United States $1.095B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.095B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.999B 4.45
Endo (ENDP) Ireland $0.951B 1.67
ArQule (ARQL) United States $0.934B 0.00
TherapeuticsMD (TXMD) United States $0.890B 0.00
Concordia (CXRXF) Canada $0.770B 0.00
Karyopharm Therapeutics (KPTI) United States $0.734B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.654B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.589B 0.00
Organogenesis Holdings (ORGO) United States $0.574B 0.00
Akebia Therapeutics (AKBA) United States $0.568B 0.00
Flexion Therapeutics (FLXN) United States $0.555B 0.00
Lannett Co Inc (LCI) United States $0.543B 5.72
Translate Bio (TBIO) United States $0.540B 0.00
ImmunoGen (IMGN) United States $0.508B 0.00
Aptorum Group (APM) China $0.491B 0.00
Dermira (DERM) United States $0.487B 0.00
Indivior (INVVY) United States $0.481B 1.74
Dova Pharmaceuticals (DOVA) United States $0.478B 0.00
Siga Technologies (SIGA) United States $0.469B 1.10
Innate Pharma SA (IPHYF) France $0.455B 0.00
ChemoCentryx (CCXI) United States $0.443B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.434B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.428B 19.44
Collegium Pharmaceutical (COLL) United States $0.416B 0.00
Harpoon Therapeutics (HARP) United States $0.392B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.370B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.347B 0.00
DURECT (DRRX) United States $0.336B 0.00
OptiNose (OPTN) United States $0.323B 0.00
Ardelyx (ARDX) United States $0.317B 0.00
CV Sciences (CVSI) United States $0.309B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.300B 0.00
Xeris Pharmaceuticals (XERS) United States $0.297B 0.00
Rafael Holdings (RFL) United States $0.291B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.282B 0.00
Recro Pharma (REPH) United States $0.268B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.267B 0.00
KalVista Pharmaceuticals (KALV) United States $0.263B 0.00
Concert Pharmaceuticals (CNCE) United States $0.260B 0.00
Molecular Templates (MTEM) United States $0.227B 0.00
Calithera Biosciences (CALA) United States $0.220B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.216B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.214B 0.00
CannTrust Holdings (CTST) Canada $0.212B 0.00
Ocular Therapeutix (OCUL) United States $0.206B 0.00
GlycoMimetics (GLYC) United States $0.202B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 31.81
Generex Biotechnology (GNBT) United States $0.173B 0.00
Redhill Biopharma (RDHL) Israel $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.161B 0.00
IMV INC (IMV) Canada $0.153B 0.00
MEI Pharma (MEIP) United States $0.142B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.140B 0.00
Cardiome Pharma (CORV) Canada $0.132B 0.00
ElectroCore (ECOR) United States $0.115B 0.00
Jounce Therapeutics (JNCE) United States $0.113B 0.00
Majesco Entertainment (PTE) United States $0.113B 0.00
Mast Therapeutics (SVRA) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.105B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
Genocea Biosciences (GNCA) United States $0.094B 0.00
AgeX Therapeutics (AGE) United States $0.094B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.092B 0.00
Iterum Therapeutics (ITRM) Ireland $0.090B 0.00
Aquestive Therapeutics (AQST) United States $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.088B 0.00
MediWound (MDWD) Israel $0.086B 0.00
Champions Oncology (CSBR) United States $0.080B 690.00
RENEURON GP (RNUGF) United Kingdom $0.079B 0.00
Nivalis Therapeutics (ALPN) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 29.12
Entasis Therapeutics Holdings (ETTX) United States $0.075B 0.00
Natural Alternatives (NAII) United States $0.075B 7.47
Novan (NOVN) United States $0.075B 0.00
Lipocine (LPCN) United States $0.073B 0.00
Infinity Pharmaceuticals (INFI) United States $0.070B 0.00
Jaguar Animal Health (JAGX) United States $0.066B 0.00
Otonomy (OTIC) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
China SXT Pharmaceuticals (SXTC) China $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
Capnia (SLNO) United States $0.057B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.048B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 1.61
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Aclaris Therapeutics (ACRS) United States $0.046B 0.00
India Globalization Capital (IGC) United States $0.044B 0.00
Melinta Therapeutics (MLNT) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Opexa Therapeutics (ACER) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
PharmAthene (ALT) United States $0.034B 0.00
Biomerica (BMRA) United States $0.031B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.020B 0.00
Achieve Life Sciences (ACHV) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Vical (BBI) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Onconova Therapeutics (ONTX) United States $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.005B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00